Clinical Trial Update: Bomedemstat (IMG-7289) in Combination With Momelotinib in Patients With Myelofibrosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating bomedemstat in combination with momelotinib for myelofibrosis, with the study status listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• Bomedemstat (bomedemstat)
• Momelotinib (momelotinib)

Snippet

Sponsor: United Lincolnshire Hospitals NHS Trust | Conditions: Myelofibrosis | Phase 2 | Status: NOT_YET_RECRUITING